Astellas Pharma (JP:4503) has launched an replace.
Astellas Pharma’s PADCEV, together with KEYTRUDA, has obtained a optimistic CHMP opinion for first-line remedy of superior...
Astellas Pharma (JP:4503) has launched an replace.
Astellas Pharma Inc.’s zolbetuximab, a novel therapy for superior gastric and gastroesophageal junction most cancers, has obtained...
Every month, lots of of individuals ask Google about breast most cancers eating regimen cures.
Somewhat than spitting out lists of obscure cancer-fighting meals...